Furthermore, blocking CXCL12 binding to CXCR4 with the plerixafor (AMD3100) inhibitor disrupts MM cell interaction with the BM microenvironment (119), causing MM cell mobilization into the circulation (120) (Figure 1). The gene discussed is CXCL12; the disease is Miyoshi myopathy.